Patient Registry Software Market Updates

Patient Registry Software Market size was valued at USD 1.87 Billion in 2023 and is poised to grow from USD 2.15 Billion in 2024 to USD 6.57 Billion by 2032, growing at a CAGR of 15.02% during the forecast period (2025-2032).

Creating solutions and systems that can be easily integrated with the current healthcare ecosystem should be the prime focus of patient registry software companies going forward. Patient registry software providers should focus on developing affordable solutions to maximize their business in all parts of the world. Patient registry software companies can also focus on collaborations and partnerships to widen their business horizons around the world.   'IQVIA Holdings ', 'Opentext Corporation ', 'Optum ', 'Premier Inc. ', 'Syneos Health ', 'Figmd ', 'Imagetrend, Inc. ', 'DACIMA Software, Inc. ', 'Global Vision Technologies, Inc. ', 'IFA Systems AG ', 'Medstreaming- M2S ', 'McKesson Corporation ', 'Evado Clinical ', 'WIRB Copernicus Group ', 'Arbormetrix, Inc. ', 'Conduent, Inc. ', 'Elekta AB ', 'Ordinal Data, Inc. ', 'ESO Solutions ', 'Lumedx ', 'Armus Corp ', 'Cedaron ', 'Versafrom Systems Corp'

Increasing need for real-world evidence in healthcare research and decision-making for regulatory bodies is projected to bolster the demand for patient registry software. This software helps collect data on patient outcomes, identifies long-term trends, and supports regulatory decisions with statistical data collected from patient outcomes thereby making it a mainstay for healthcare R&D in the future.  

Use of Artificial Intelligence and Machine Learning Technologies: Patient registry software companies can leverage the use of artificial intelligence and machine learning technologies to provide automation capabilities in their offerings. These technologies can also offer predictive analytics and better insights to improve patient care and outcomes in the future thereby making it an unmissable patient registry software market trend through 2031.  

North America is anticipated to account for a dominant share of the global patient registry software market. The presence of a developed healthcare infrastructure, high emphasis on healthcare digitization, and quick adoption of advanced technologies are allowing North America to lead the global patient registry software industry. Canada and the United States are expected to be highly opportune markets owing to high emphasis on improvement of patient outcomes in these countries. Growing investments in healthcare research and development in this region are also expected to bolster the demand for patient registry software going forward. The presence of leading patient registry software providers is also expected to further bolster the dominance of North America.